Rexulti

(brexpiprazole; atypical antipsychotics) Otsuka

Available strengths:

• Tablets with each contains 0.5 mg, 1 mg, 2 mg or 3 mg of brexpiprazole for oral use

Indication:

• Indicated for the treatment of schizophrenia

Drug information including formulation, indication, administration and/or presentation updated, registered or launched in Hong Kong within one year prior to the date written is regarded as new in The Pace.

The information in The Pace is provided as a courtesy service to our readers and is intended for medical professional reference only. Please peruse the latest local prescription information prior to prescription.